Extrahepatic metabolism of frusemide in anaesthetized rabbits

British Journal of Pharmacology
J VergésP du Souich

Abstract

1. Frusemide is removed from the body by biotransformation and renal secretion, but since frusemide metabolism is not altered in patients with hepatic cirrhosis, the role of the liver may be questioned. The aim of the study was to investigate which organs contribute to the first-pass metabolism and systemic clearance of frusemide. 2. Groups of anaesthetized New Zealand rabbits were administered frusemide proximally (prox) and distally (dist) to different organs, and blood was sampled from the abdominal aorta. The area under frusemide plasma concentrations-time curve (AUC0-infinity) was calculated and frusemide extraction by an organ was estimated from the ratio (AUCdist-AUCprox)/AUCdist. The small intestine extracted 83% of the absorbed dose of frusemide but the first-pass uptake by the liver and lungs was negligible. 3. To assess the contribution of the intestine and the kidneys to the systemic clearance of frusemide, it was injected into the jugular vein and blood was sampled proximal and distal to each organ. The kidneys extracted 24% of frusemide circulating in the renal arteries; on the other hand, the ability of the intestine to extract frusemide from the systemic circulation could not be detected. 4. The lungs did not me...Continue Reading

References

Oct 1, 1977·Clinical Pharmacology and Therapeutics·M HomeidaR A Branch
Aug 17, 1977·European Journal of Clinical Pharmacology·F Andreasen, E Mikkelsen
Sep 1, 1992·Trends in Pharmacological Sciences·F J Gonzalez
Jan 1, 1992·Life Sciences·F P Guengerich
Jun 1, 1991·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J Prandota, A W Pruitt
Feb 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·M Hammarlund-Udenaes, L Z Benet
May 1, 1987·Clinical Pharmacology and Therapeutics·A RakhitM E Hurley
Jul 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G M PacificiG B Muraro
Aug 1, 1987·Journal of Pharmacobio-dynamics·J B Zhu, T Koizumi
Oct 1, 1974·Clinical Pharmacology and Therapeutics·C M HuangA Quintanilla
Jun 1, 1974·Clinical Pharmacology and Therapeutics·R E CutlerB M Kimpel
Jan 1, 1980·The Journal of Pharmacy and Pharmacology·M K Cassidy, J B Houston
Jan 1, 1983·European Journal of Clinical Pharmacology·D E Smith, L Z Benet
Dec 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·M G Lee, W L Chiou
Aug 1, 1983·Clinical Pharmacology and Therapeutics·A L KerremansF W Gribnau
Oct 1, 1981·Clinical Pharmacology and Therapeutics·R FullerS T Ingalls
Feb 1, 1994·Clinical Pharmacokinetics·D R Krishna, U Klotz
Oct 1, 1993·Clinical Pharmacokinetics·Y K Tam

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.